About ICF

Ellen Munemo

Senior Manager, Infectious Disease Detection and Surveillance (IDDS) Team Lead
Monrovia, Liberia

Ellen is a global health expert with more than 20 years of experience in laboratory system strengthening.

Ellen Munemo (M.Sc.) is the team lead for the United States Agency for International Development’s (USAID) Infectious Disease Detection and Surveillance (IDDS) project in Liberia. She has a passion for improving healthcare outcomes through robust diagnostic processes and utilizes her expertise to optimize and manage laboratory processes while implementing integrated advanced technologies to enhance diagnostic capabilities. Over the years, Ellen honed her skills in optimizing workflows, implementing cutting-edge technologies and establishing quality control measures.

Ellen dedicates her career to enhancing laboratory systems in Africa and contributes invaluable expertise to global health initiatives. She plays a pivotal role in strengthening and optimizing workflows, implementing cutting-edge technologies, and establishing quality control measures. Ellen possesses a deep understanding of laboratory practices and is instrumental in implementing strategies to improve healthcare outcomes. Through collaborative efforts and strategic planning, she plays a key role in advancing laboratory capabilities, ultimately enhancing healthcare delivery and promoting better health outcomes.

Ellen’s success lies in technical proficiency and her ability to inspire and train local teams. She believes in sustainability and empowering local professionals to manage and enhance their laboratory systems independently. Her impact is evident in the improved accuracy and efficiency of diagnostic services in the regions where she has worked.

Earlier in her career, Ellen was a program director for a University of Massachusetts health systems strengthening project, funded by the U.S. Centers for Disease Control and Prevention and the Academic Consortium Combating Ebola in Liberia (ACCEL). She successfully implemented the capacity-building mentorship models in Liberian healthcare facilities. And, she led the implementation of the Stepwise Laboratory Management Toward Accreditation (SLMTA) model for laboratory quality management systems in all 15 counties in Liberia.

Ellen also has vast experience working in tuberculosis (TB) prevention and control, served as a TB laboratory consultant in various African countries, and successfully led the National Microbiology Reference Laboratory in Zimbabwe to ISO 15189 accreditation.

Ellen earned a master’s degree in microbiology and immunology, a Specialist Diploma in Medical Laboratory Technology in bacteriology and mycology. She holds certification in global health delivery, diagnostic network optimization and leadership development.

Education
  • M.Sc., Medical Microbiology, Microbiology and Immunology, University of Zimbabwe
  • Specialist Diploma in Medical Laboratory Technology in Bacteriology including Mycology, University of Zimbabwe
  • Diploma in Medical Laboratory Technology, University of Zimbabwe
  • Certificate, Global Health Delivery, Harvard
  • Certificate, Diagnostic Network Optimization, Find Diagnostics
Publications
  • “Ciprofloxacin Resistant Salmonella Typhi Isolated at National Microbiology Reference Laboratory in Harare, Zimbabwe (January to April 2016),” Open Public Health Journal, 2020.
  • “Laboratory Characterisation of Salmonella Enterica Serotype Typhi Isolates From Zimbabwe, 2009–2017,” BMC Infectious Diseases, 2019.
  • “Mutations in rpoB and katG Genes of Multidrug-Resistant Mycobacterium Tuberculosis Undetectable Using Genotyping Diagnostic Methods,” Pan African Medical Journal, 2017.
  • “Molecular Detection of Mycobacterium Tuberculosis Rifampicin Drug Resistance Using rpoB Gene Sequencing in Zimbabwe,” British Microbiology Research Journal, 2016.
  • “Molecular Identification of Nontuberculous Mycobacteria in Humans in Zimbabwe Using 16S Ribosequencing,” The Open Microbiology Journal, 2016.
  • “First Cases of Mycobacterium Elephantis in Zimbabwe Revealed by 16S Ribosequencing,” Archives of Clinical Microbiology, 2015.

Insights